You are here
,

Lilly cancer drug fails key trial, will no longer be prescribed

  • Tuesday, 22 January 2019
  • Posted by Aftab Ahmad
  • 0 Comments
Eli Lilly and Co said on Friday that its cancer treatment Lartruvo, which had won conditional approval, failed to improve patient survival in a long-term confirmatory study and will no longer be prescribed, driving the drugmaker's shares down nearly 3 percent.


from Reuters: Health News https://reut.rs/2RCPqmm

Aftab Ahmad

We are.., This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

No comments:

Leave a Reply